Literature DB >> 16483119

Difficult-to-engage patients: a specific target for time-limited assertive outreach in a Swiss setting.

Charles Bonsack1, Laurence Adam, Thomas Haefliger, Jacques Besson, Philippe Conus.   

Abstract

OBJECTIVE: Assertive community treatment (ACT) failed to develop in Europe, and its efficacy is debated. In Lausanne, Switzerland, ACT focuses on difficult-to-engage patients and aims to facilitate linkage with outpatient care through time-limited interventions. This study aimed to evaluate the applicability and efficiency of time-limited ACT.
METHODS: We retrospectively assessed social, clinical, and functional outcomes and motivation for treatment in 75 consecutively seen subjects treated between 2000 and 2002.
RESULTS: With 70% of the interventions lasting less than 6 months, we observed significant improvement in most clinical and social problems, in collaboration, in motivation for treatment, and in social network support, despite high baseline levels of clinical and social problems. The number of hospitalizations decreased significantly.
CONCLUSIONS: Time-limited ACT is a useful treatment for difficult-to-engage patients with severe clinical and social problems, and it facilitates linkage to care. This narrower target for ACT may facilitate its implementation in Europe.

Entities:  

Mesh:

Year:  2005        PMID: 16483119     DOI: 10.1177/070674370505001307

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  8 in total

1.  Assertive Community Programs for Patients with Severe Mental Disorders: Are Benefits Sustained After Discharge?

Authors:  Sonia Vidal; Nader Perroud; Leire Correa; Philippe Huguelet
Journal:  Community Ment Health J       Date:  2019-12-05

2.  Effectiveness of crisis resolution home treatment for the management of acute psychiatric crises in Southern Switzerland: a natural experiment based on geography.

Authors:  Luca Crivelli; Rafael Traber; Emiliano Soldini; Maddalena Alippi; Maria Caiata Zufferey; Angela Lisi; Mario Lucchini; Emiliano Albanese; Raffaella Ada Colombo; Simona Rossa; Emilio Bolla; Zefiro Benedetto Mellacqua; Giuseppina Larghi; Severino Cordasco; Wolfram Kawohl
Journal:  BMC Psychiatry       Date:  2022-06-17       Impact factor: 4.144

3.  Do Home-Based Psychiatric Services for Patients in Medico-Social Institutions Reduce Hospitalizations? Pre-Post Evaluation of a French Psychiatric Mobile Team.

Authors:  Sophie Cervello; Mael Pulcini; Catherine Massoubre; Béatrice Trombert-Paviot; Eric Fakra
Journal:  Psychiatr Q       Date:  2019-03

4.  Intensive Case Management for Addiction to promote engagement with care of people with severe mental and substance use disorders: an observational study.

Authors:  Stéphane Morandi; Benedetta Silva; Philippe Golay; Charles Bonsack
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-05-25

5.  Patterns of Service Use in Intensive Case Management: A Six Year Longitudinal Study.

Authors:  Philippe Golay; Charles Bonsack; Benedetta Silva; Guillaume Pauli; Eva de Boer; Stéphane Morandi
Journal:  Adm Policy Ment Health       Date:  2022-05-16

6.  A real-life observational study of the effectiveness of FACT in a Dutch mental health region.

Authors:  Marjan Drukker; Myrte Maarschalkerweerd; Maarten Bak; Ger Driessen; Joost à Campo; Arthur de Bie; Giovanni Poddighe; Jim van Os; Philippe Delespaul
Journal:  BMC Psychiatry       Date:  2008-12-04       Impact factor: 3.630

7.  Hospitalization of high and low inpatient service users before and after enrollment into Assertive Community Treatment teams: a naturalistic observational study.

Authors:  Hanne Clausen; Anne Landheim; Sigrun Odden; Jūratė Šaltytė Benth; Kristin Sverdvik Heiervang; Hanne Kilen Stuen; Helen Killaspy; Torleif Ruud
Journal:  Int J Ment Health Syst       Date:  2016-02-29

8.  Factors associated with involuntary hospitalisation for psychiatric patients in Switzerland: a retrospective study.

Authors:  Benedetta Silva; Philippe Golay; Stéphane Morandi
Journal:  BMC Psychiatry       Date:  2018-12-29       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.